ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 86 filers reported holding ALLOVIR INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $13,736 | -53.7% | 6,389 | -26.7% | 0.00% | -100.0% |
| Q2 2023 | $29,655 | +370587.5% | 8,722 | +315.9% | 0.00% | – |
| Q1 2023 | $8 | -79.5% | 2,097 | -72.7% | 0.00% | -100.0% |
| Q4 2022 | $39 | -99.8% | 7,679 | +158.4% | 0.00% | – |
| Q3 2022 | $23,000 | -11.5% | 2,972 | -54.9% | 0.00% | -100.0% |
| Q2 2022 | $26,000 | -29.7% | 6,586 | +20.7% | 0.00% | – |
| Q1 2022 | $37,000 | -7.5% | 5,455 | +77.9% | 0.00% | -100.0% |
| Q4 2021 | $40,000 | -36.5% | 3,067 | +22.8% | 0.00% | -50.0% |
| Q3 2021 | $63,000 | +46.5% | 2,497 | +14.3% | 0.00% | +100.0% |
| Q2 2021 | $43,000 | +13.2% | 2,185 | +32.8% | 0.00% | 0.0% |
| Q1 2021 | $38,000 | -83.0% | 1,645 | -71.7% | 0.00% | -85.7% |
| Q4 2020 | $223,000 | +120.8% | 5,807 | +58.3% | 0.01% | +600.0% |
| Q3 2020 | $101,000 | – | 3,668 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Artal Group S.A. | 5,577,167 | $44,004,000 | 1.88% |
| GMT CAPITAL CORP | 2,758,846 | $21,767,000 | 1.35% |
| Regency Capital Management Inc.\DE | 75,010 | $592,000 | 0.73% |
| Redmile Group, LLC | 1,907,969 | $15,054,000 | 0.58% |
| Samsara BioCapital, LLC | 82,336 | $650,000 | 0.15% |
| Alkeon Capital Management | 4,923,104 | $38,843,000 | 0.13% |
| Woodline Partners LP | 1,087,093 | $8,577,000 | 0.12% |
| GSA CAPITAL PARTNERS LLP | 77,625 | $612,000 | 0.08% |
| CORNERCAP INVESTMENT COUNSEL INC | 44,987 | $355,000 | 0.07% |
| AMERICAN INTERNATIONAL GROUP, INC. | 1,143,634 | $9,023,000 | 0.07% |